CLYM

NASDAQ · Biotechnology

Climb Bio Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.99

+0.12 (+1.35%)

As of Nov 7, 2:08 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +190.4% upside

Low Target $17.52

Average Target $26.11

High Target $31.20

Current Price $8.99

Current
$8.99

Target
$26.11

$17.52 $26.11 avg $31.20

Scenario Analysis

Bear Case

$17.52

94.9%

Low target

Base Case

$26.11

+190.4%

Avg target

Bull Case

$31.20

+247.1%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$18.33

-51.0% from high

52-Week Low

$1.64

+449.8% from low

Target vs 52W High

$26.11

+42.4% vs high

Next Earnings Report

Nov 11, 2026

until earnings

EPS Est: $-0.21

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%